Skip to main content

Genpact LTD

corporate_fare Company Profile

Genpact LTD

G·NYSE·Trade & Services·CIK 0001398659

Genpact is an advanced technology solutions company that provides innovative solutions to transform how businesses operate. The company leverages its industry knowledge, process intelligence, and expertise in "last mile" execution. Genpact has over 146,500 employees and serves clients from more than 35 countries globally. In 2025, the company reported total net revenues of $5.1 billion. Genpact was founded over 25 years ago as the global capability center for the General Electric Company ("GE"), initially focusing on perfecting shared business processes using Lean Six Sigma and other methodologies. This background established Genpact as a leading expert in business processes, developing core competencies in process design, data management, and industry domain knowledge. The company utilizes this process intelligence to deliver AI and agentic solutions that address operational complexities and "last mile" execution challenges for clients. Genpact embeds AI to drive enterprise-wide value by building agentic solutions that act and learn alongside humans. The company supports mission-critical operations for leading global companies, utilizing its Advanced Technology Solutions, including Data and AI and Agentic Solutions, to reengineer business processes, build data and AI capabilities, and lead with agentic collaboration.

Genpact LTD (NYSE:G) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 14 items for G at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for G spans 10-Q, 8-K, S-4/A, S-4.

Recent high-impact activity:

  • Genpact 10-Q: Q3 Revenue Up 7.3%, but Operating Cash Flow Falls 73% on ERP-Driven Receivables Build
  • Genpact Q3 Revenue Up 7.3% to $1.385B; Raises 2026 Margin and EPS Guidance
  • Genpact Posts Q3 Adjusted EPS of $1.07
  • Genpact Files Amended S-4 Detailing Bermuda-to-Delaware Domestication, Tax Consequences
  • Genpact Names Sumita Pandit CFO; Michael Weiner Steps Down After Transition

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$5.08B
Net Income
$552.49M
Diluted EPS
$3.13
Op. Cash Flow
$812.86M
Free Cash Flow
$734.65M
Gross Profit
$1.83B
Operating Income
$750.21M
Cash & Equivalents
$853.84M
Total Debt
$1.54B
Debt / Equity
0.60×
Net Margin
10.9%
Shares Outstanding
170.34M sh
Source: 10-K · filed 2026-02-26 · accession 0001398659-26-000004

Short Interest & Short Volume

5.95 days to cover

FINRA reported short interest of 10,683,874 shares in G as of the October 30, 2026 settlement, a 3.6% decrease from the prior period — about 6.0 days to cover at its recent average daily volume. On November 20, 2026, 78.3% of G volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)10,683,874 shares as of October 30, 2026
Change vs prior period▼ 3.6%
Days to cover5.95 at avg daily volume of 1,796,056
Daily short volume (FINRA facilities)78.3% of 766,517 shares on November 20, 2026
5-day average short volume67.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with G →
$41.5
52-week range · as of 2026-11-06 $26.85 – $48.64
Market cap
$6.94B
Volume
1.8M (0.9× avg)
3-mo avg 2.1M
Live data · 2026-11-22 11:46 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed G - Latest Insights

G
Nov 06, 2026, 1:11 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $41.89
Real-time Price: $41.50 info
Change: -$0.390 (-0.93%) info
Market Cap: $6.94B info
G
Nov 05, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
7
Updated Nov 5, 4:56 PM ET — Genpact's Q3 adjusted income from operations was $247 mln, beating the $240.33 mln consensus estimate.
Price at Filing: $41.10
Real-time Price: $41.50 info
Change: +$0.400 (+0.97%) info
Market Cap: $6.94B info
G
Nov 05, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $41.10
Real-time Price: $41.50 info
Change: +$0.400 (+0.97%) info
Market Cap: $6.94B info
G
Sep 17, 2026, 4:04 PM EDT
Filing Type: S-4/A
Importance Score:
7
Price at Filing: $34.95
Real-time Price: $41.50 info
Change: +$6.55 (+19%) info
Market Cap: $6.94B info
G
Sep 08, 2026, 9:01 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.32
Real-time Price: $41.50 info
Change: +$4.18 (+11%) info
Market Cap: $6.94B info
G
Aug 19, 2026, 4:10 PM EDT
Filing Type: S-4
Importance Score:
7
Price at Filing: $36.40
Real-time Price: $41.50 info
Change: +$5.10 (+14%) info
Market Cap: $6.94B info
G
Aug 06, 2026, 6:25 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $34.67
Real-time Price: $41.50 info
Change: +$6.83 (+20%) info
Market Cap: $6.94B info
G
Aug 06, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $36.16
Real-time Price: $41.50 info
Change: +$5.34 (+15%) info
Market Cap: $6.94B info
G
May 08, 2026, 11:42 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $31.95
Real-time Price: $41.50 info
Change: +$9.56 (+30%) info
Market Cap: $6.94B info
G
May 07, 2026, 4:34 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $34.92
Real-time Price: $41.50 info
Change: +$6.58 (+19%) info
Market Cap: $6.94B info
G
May 07, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $34.92
Real-time Price: $41.50 info
Change: +$6.58 (+19%) info
Market Cap: $6.94B info
G
May 07, 2026, 8:12 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $33.75
Real-time Price: $41.50 info
Change: +$7.75 (+23%) info
Market Cap: $6.94B info
G
Feb 26, 2026, 12:14 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $39.06
Real-time Price: $41.50 info
Change: +$2.45 (+6%) info
Market Cap: $6.94B info
G
Feb 05, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $38.47
Real-time Price: $41.50 info
Change: +$3.03 (+8%) info
Market Cap: $6.94B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets